Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

MAKO Surgical gets $40mm via private placement; could add $20mm

Executive Summary

MAKO Surgical (implants for minimally invasive orthopedic procedures) announced a private placement that could bring in $60mm. The company initially grossed $40mm through the sale of 6.45mm common shares at $6.20 each (a 9% discount) to lead and first-time investors Montreux Equity Partners and Skyline Ventures, which each add a representative to the board. Other new backer Alta Partners was joined by returning shareholders Ziegler Meditech Equity Partners, MK Investment Company, Lumira Capital, Aperture Venture Partners, and two company board members. MAKO also issued seven-year warrants to buy another 1.29mm shares exercisable at $7.44. The company could bring in another $20mm by the end of 2009 if certain milestones are met.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies